News and press releases

Biocogniv Receives FDA Breakthrough Designation for Sepsis aiMarker™

The designation marks the company's first regulatory milestone.

April 7, 2023

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Biocogniv Powers UTMB’s Award-Winning COVID-19 Program

UTMB was recognized with a 2022 Gage Award for its COVID-19 Innovation by America’s Essential Hospitals.

July 27, 2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Biocogniv Featured in FastCompany Magazine

Read how Biocogniv's real-time, cloud-based platform clinOS™ was used by UTMB to power over 1 Million laboratory interpretations.

July 11, 2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Biocogniv Closes $6M in Seed Funding Led By Breyer Capital to Advance Digital Diagnostic Platform

Company Adds Multiple Healthcare Industry Leaders to Advisory Board

March 16, 2022

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.